FDA Drug recall D-0242-2026
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp…
- FDA Drug
- Class II
- ongoing
- Published 2025-12-31
On 2025-12-31 the FDA classified a Class II recall of Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp… by Merck Sharp And Dohme, citing presence of particulate matter: potential presence of metal particulates in the product.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0242-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2025-12-12 |
| Published | 2025-12-31 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Merck Sharp And Dohme |
| Distribution | US |
Product
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Reason
Presence of particulate matter: potential presence of metal particulates in the product.
Identifiers
| ndc | 0085-1328-01 |
|---|---|
| ndc | 0085-4324-02 |
| ndc | 0085-4331-01 |
| ndc | 0085-2224-01 |
| ndc | 0085-2224-02 |
| code_info | Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0242-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.